Clinical trial
Effects of Replacing Lantus With Basalin on the Glycemic Variation in Patients
NCT03631121 is registered in ClinicalTrials.gov with Nanjing First Hospital, Nanjing Medical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effects of Replacing Lantus With Basalin on the Glycemic Variation in Patients
- Lead sponsor
- Nanjing First Hospital, Nanjing Medical University
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- August 15, 2018
- Completion date
- July 30, 2019
- Enrollment
- 100 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
type2 diabetes